Kachhadia, M.P. (2026) “Sodium-Glucose Co-Transporter 2 Inhibitor Use and Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis and Type 2 Diabetes: A Retrospective Observational Cohort Study Using Real-World Data”, Journal of Clinical Medicine Research, 18(5), pp. 313–325. doi:10.14740/jocmr6577.